25 related articles for article (PubMed ID: 17404019)
1. Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.
Konings G; Brentjens L; Delvoux B; Linnanen T; Cornel K; Koskimies P; Bongers M; Kruitwagen R; Xanthoulea S; Romano A
Front Pharmacol; 2018; 9():940. PubMed ID: 30283331
[TBL] [Abstract][Full Text] [Related]
2. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies.
Watanabe K; Sasano H; Harada N; Ozaki M; Niikura H; Sato S; Yajima A
Am J Pathol; 1995 Feb; 146(2):491-500. PubMed ID: 7856758
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone receptor expression in endometrial cancer.
Jeon YT; Kim YB; Park SY; Kim JW; Park NH; Kang SB; Song YS
Int J Gynecol Pathol; 2009 Jan; 28(1):19-22. PubMed ID: 19047913
[TBL] [Abstract][Full Text] [Related]
4. [Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer].
Bersteĭn LM; Chernobrovkina AE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Maksimov SIa; Chepik OF; Gershfel'd ED
Vopr Onkol; 2003; 49(1):55-9. PubMed ID: 12715371
[TBL] [Abstract][Full Text] [Related]
5. CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease.
Berstein L; Zimarina T; Kovalevskij A; Maximov S; Volkov O; Thijssen JH
Neoplasma; 2005; 52(2):115-8. PubMed ID: 15800709
[TBL] [Abstract][Full Text] [Related]
6. [The risk of endometrial cancer appearance and CYP19 and COMT gene polymorphism].
Szyłło K; Smolarz B; Romanowicz-Makowska H; Przybyłowska K; Lewy J; Kulig B
Pol Merkur Lekarski; 2007 Mar; 22(129):208-10. PubMed ID: 17682677
[TBL] [Abstract][Full Text] [Related]
7. Aromatase expression was not detected by immunohistochemistry in endometrial cancer.
Jeon YT; Park SY; Kim YB; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():70-5. PubMed ID: 17404019
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies.
Sasano H; Harada N
Endocr Rev; 1998 Oct; 19(5):593-607. PubMed ID: 9793759
[TBL] [Abstract][Full Text] [Related]
9. From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures.
Boruban MC; Altundag K; Kilic GS; Blankstein J
Eur J Cancer Prev; 2008 Apr; 17(2):133-8. PubMed ID: 18287870
[TBL] [Abstract][Full Text] [Related]
10. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
11. Multiple roles of cyclooxygenase-2 in endometrial cancer.
Ohno S; Ohno Y; Suzuki N; Inagawa H; Kohchi C; Soma G; Inoue M
Anticancer Res; 2005; 25(6A):3679-87. PubMed ID: 16302726
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization analysis of biomarkers in cancer.
Mark HF
Exp Mol Pathol; 1999 Dec; 67(3):131-4. PubMed ID: 10600395
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
